We are an emerging development stage company focused on microRNA therapeutics for Oncology. In September , we entered into agreements with the Ohio State Innovation Foundation OSIF , an affiliate of the Ohio State University OSU , to exclusively license a portfolio of approximately pending patent applications and granted patents covering numerous microRNAs and their methods of use. In addition, we licensed a novel delivery technology for potential use in the development of our therapeutic product candidates.
Quote | Microlin Bio Inc (OTCMKTS:MICB)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.68 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Microlin Bio Inc (OTCMKTS:MICB)
Message Board Posts | Microlin Bio Inc (OTCMKTS:MICB)
Subject | By | Source | When |
---|---|---|---|
MICB FINRA deleted symbol, awaiting A.L.J. revocation: | Renee | investorshub | 10/11/2018 9:36:03 PM |
MICB SEC Suspension for delinquent Financials/Filings: | Renee | investorshub | 09/26/2017 1:48:20 PM |
The little bit of 2.35's were taken out. | $hellKing | investorshub | 04/01/2016 10:52:15 PM |
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets | $hellKing | investorshub | 03/17/2016 8:12:18 PM |
Come on! I know you are gonna | $hellKing | investorshub | 03/10/2016 2:49:28 AM |
News, Short Squeeze, Breakout and More Instantly...